A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9
Clinical trial NCT02946606 · COMPLETED
Trial details
- NCT number
- NCT02946606
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-12-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.